Hemu Wang
3Patents
3Active
3Granted
41Portfolio score
Filing activity: Mar 16, 2017 → Mar 16, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10821174B2 | Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine | Chemistry; Metallurgy | 1 | Active |
| US10653772B2 | Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg | Chemistry; Metallurgy | 1 | Active |
| US11191829B2 | Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.